Drug intelligence / Profile preview

ubiquinol acetate

Development stage
Unknown
Lead developer
Allastir
Modality
Small Molecules
Administration
Oral
01

Overview

Ubiquinol acetate is a stabilized ester derivative of ubiquinol, which is the reduced, electron-rich form of Coenzyme Q10 (CoQ10). Developed as a nutraceutical and pharmaceutical ingredient, it serves as a precursor that is converted into active ubiquinol within the body. Ubiquinol is a vital component of the mitochondrial electron transport chain, facilitating the transfer of electrons to generate adenosine triphosphate (ATP). Additionally, it acts as a potent lipid-soluble antioxidant, protecting cell membranes and lipoproteins from oxidative damage. The acetate formulation is specifically designed to improve the stability of ubiquinol, which is otherwise highly susceptible to oxidation back to ubiquinone (the oxidized form of CoQ10). It is primarily utilized in formulations targeting cardiovascular health, mitochondrial support, and healthy aging.

Other names
ubiquinol-10 acetateubiquinol10 acetateubiquinol 10 acetatecoenzyme Q10 acetatereduced coenzyme Q10 acetate
02

Targets

SDH (Mitochondrial electron transport chain complex II)NADH:ubiquinone oxidoreductase subunit familyUbiquinol-cytochrome c reductase

Beyond the preview

Go deeper on ubiquinol acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ubiquinol acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call